Evestra, Inc.
- UEI
- JDELV4PXM7Z3
- CAGE
- 55QQ2
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Website
- evestra.com
- Founded
- 2020
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Targeting LIF/lifr in pancreatic cancer | National Cancer Institute (NIH) | $3,636,788 | |
| Targeted inhibition of leukemia inhibitory factor (LIF)/lifr axis for the treatment of triple-negative breast cancer | Medical Command (Army) | $960,000 |
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| The University Of Texas Health Science Center At San Antonio | R01CA266970 | $605,130 |
Quick answers
Is Evestra, Inc. registered in SAM.gov?
Evestra, Inc.'s SAM.gov registration expired on April 17, 2026.
What is Evestra, Inc.'s most recent federal award?
Evestra, Inc.'s most recent federal grant award is Targeting LIF/lifr in pancreatic cancer (R44CA235991), from National Cancer Institute (NIH), on April 2, 2019.
On GovTribe
See Evestra, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors